PMID: 8961369Oct 1, 1996Paper

External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
K A VallisP Price

Abstract

Cholangiocarcinoma is rare but carries a poor prognosis. Radiotherapy has been used either as an adjuvant treatment following surgical resection of tumour or for palliation. The purpose of this study was to assess the feasibility and morbidity of accelerated external beam radiotherapy with or without intraluminal radiotherapy in the treatment of locally advanced bile duct cancer. Thirty eight patients were treated. Surgical procedures performed prior to radiotherapy were extended hepatectomy (3), hepaticojejunostomy with tumour resection (6), palliative biliary-enteric bypass (6), biopsy (4), Whipple's procedure (1), gastrojejunostomy (1) and cholecystectomy (1). Twenty patients received external beam radiotherapy (ERT). Six patients received one Phase of ERT and 12 received two Phases, separated by a 2-week gap. Dose per Phase was 22.5 Gy in 10 twice daily fractions. After 1989, dose per Phase was increased to 27.5 Gy. One patient received Phase I ERT (30.0 Gy) using conventional fractionation and one patient received an uninterrupted, conventionally fractionate course of treatment (50.0 Gy). Fourteen patients received both ERT and intraluminal radiotherapy (IRT) using iridium-192 (192Ir) wire passed through a percutaneous, tr...Continue Reading

References

Jun 1, 1978·Radiology·M V Pilepich, P M Lambert
Nov 1, 1992·Clinical Radiology·A Adam, I S Benjamin
Jan 1, 1990·American Journal of Surgery·J L CameronJ Coleman
Feb 1, 1991·AJR. American Journal of Roentgenology·A AdamI S Benjamin
Jun 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M MaheJ P Gerard
May 1, 1990·Seminars in Liver Disease·D González GonzálezJ D Van Dijk
May 1, 1990·International Journal of Radiation Oncology, Biology, Physics·B D MinskyD Nori
Feb 1, 1985·International Journal of Radiation Oncology, Biology, Physics·D W JohnsonD R Goffinet
Jun 1, 1989·Annals of Surgery·W C ChapmanJ L Sawyers
Sep 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J K HayesF J Miller
Mar 1, 1987·International Journal of Radiation Oncology, Biology, Physics·J N Fields, B Emami
Jun 1, 1988·International Journal of Radiation Oncology, Biology, Physics·M Hauer-JensenJ W Osborne
Nov 1, 1984·International Journal of Radiation Oncology, Biology, Physics·S J BuskirkJ K Martin
Dec 1, 1984·International Journal of Radiation Oncology, Biology, Physics·T D Fogel, J B Weissberg
Jul 1, 1994·International Journal of Radiation Oncology, Biology, Physics·P FritzM Wannenmacher
Jan 1, 1993·Annals of Surgery·H U BaerL H Blumgart

❮ Previous
Next ❯

Citations

Nov 26, 2008·World Journal of Gastroenterology : WJG·Yucel Ustundag, Yusuf Bayraktar
Mar 30, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Felix MommGerhild Becker
Oct 16, 2007·Surgical Oncology·Steven C CunninghamTimothy M Pawlik
Jul 16, 2005·Surgical Oncology·D SinghalD J Gouma
Oct 18, 2007·The Korean Journal of Internal Medicine·Sin Hyung LimWoong Chul Lee
Nov 7, 2000·Journal of Surgical Oncology·P D GarnerP A Johnstone
Aug 8, 2006·Current Opinion in Gastroenterology·Prabhleen Chahal, Todd H Baron
Feb 3, 2004·The Oncologist·Christopher D AndersonRavi S Chari
Feb 24, 2001·American Journal of Clinical Oncology·R OveO Haluszka
Dec 8, 2010·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Thomas B Brunner, Cynthia L Eccles
Feb 16, 2000·Annals of Surgical Oncology·R S Chamberlain, L H Blumgart
Dec 29, 2000·Seminars in Surgical Oncology·W R Jarnagin
Feb 1, 2003·Acta medica Austriaca·Ramona MayerA Hackl
Nov 5, 2010·Journal of Gastrointestinal Cancer·Eugene LeongNigel Spry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.